Antitrust is traditionally an M&A concern, but with the more aggressive approach that the Biden administration has taken towards enforcing antitrust laws, its implications are trickling down in a way CVCs in the US market can’t ignore.
GCV senior reporter Kim Moore is back with us to talk about the rising antitrust scrutiny in the US market and the effect it can have on how CVCs may look at investing, reaching exits or even considering the board seats they take.
What can CVCs do to mitigate their exposure to antitrust risk? And, while it may present short-term concerns, what potential does this heightened enforcement of competition law have in actually improving the conditions for innovation?
 |  |  |  |  |  |  |  |
